BobcatBio
PrivateLast Round
Series A
Extension
Feb 25, 2025
Est. Valuation
$49.8M
Total Funding Raised
$33.62M
Company Overview
BobcatBio operates in Healthcare & Life Sciences and is based in Hummelstown, Pennsylvania. Its latest recorded funding round was a Series A Extension round in February 2025.
BobcatBio is a biotechnology company that develops cancer-specific immunotherapy for the treatment of solid tumors. The company's adoptive cell therapy approach is designed to elicit a polyclonal immune response against multiple tumor antigens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BobcatBio Comparables
Compare BobcatBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carisma Therapeutics | 79% | |
| Avstera Therapeutics | 79% | |
| Pheast Therapeutics | 73% |
For institutional investors. Book with your work email.
BobcatBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 25, 2025 | ||||
| Seed | Sep 29, 2021 | ||||
| Series A | Jul 23, 2021 |
For institutional investors. Book with your work email.
BobcatBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Life Sciences Greenhouse Investments | Series A |
| Georgia Research Alliance | Series A |
| SeedFolio | Series A |
| BioAdvance Capital | Seed, Series A, Series A Extension |
| Vision Seed Capital | Seed |
| Bios Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 25, 2025
$7M round led by BioAdvance Capital
- Sep 29, 2021
$115K round from BioAdvance Capital and Vision Seed Capital.
For institutional investors. Book with your work email.
BobcatBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BobcatBio's valuation, stock price, and market status.
Is BobcatBio a public or private company?
BobcatBio is a private company.
What is the current stock price of BobcatBio?
BobcatBio is a private company, so its shares have no public market price. Caplight tracks BobcatBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BobcatBio worth (valuation)?
BobcatBio's valuation is estimated at $49.8M based on funding round data.
Can I buy BobcatBio stock?
BobcatBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BobcatBio's last funding round?
BobcatBio's most recent funding round was Series A Extension on February 25, 2025.
Who are the main investors in BobcatBio?
Key investors in BobcatBio include BioAdvance Capital.
Will BobcatBio IPO soon?
No public IPO plans have been announced for BobcatBio.
How can I track BobcatBio secondary market activity?
Caplight tracks bids, offers, and trades in BobcatBio's shares on secondary markets.